Skip to main content
Clinical Trials/IRCT20170513033941N31
IRCT20170513033941N31
Completed
Phase 3

Clinical trial of the effect of melatonin supplementation compared with the placebo on metabolic status and gene expression related to inflammation, insulin and lipid in diabetic hemodialysis patients

Kashan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hemodialysis.
Sponsor
Kashan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • diabetic hemodialysis patients
  • Individuals aged 18 to 80 years old

Exclusion Criteria

  • Patients with infectious, inflammatory and malignant diseases
  • those taking melatonin supplements, antioxidant and/or anti\-inflammatory supplements within 3 months prior to enrollment in the study
  • the night shift workers
  • subjects taking immunosuppressive and antibiotics medications
  • unwillingness to cooperate

Outcomes

Primary Outcomes

Not specified

Similar Trials